LEWISBERRY, PA--(Marketwire - November 5, 2009) - Unilife Medical Solutions Limited (ASX: UNI) (PINKSHEETS: UNIFF) wishes to advise shareholders of the release of a Finance News Network interview conducted recently with Unilife CEO Alan Shortall.

The interview can be heard via the link below or by visiting the Unilife website at www.unilife.com.

http://www.finnewsnetwork.com/Display.aspx?Site=FNN108&Vs=FNN108&Vm=Int_Unlife_ L_041109.flv|Int_Unlife_M_041109.flv|Int_Unlife_H_041109.flv&Vc=Interviews&feed=intr

About the Unilife Australia Group

Unilife Medical Solutions Ltd. is an ISO 13485 certified company that designs, develops and supplies innovative safety medical devices. Listed on the Australian Securities Exchange (ASX: UNI) since 2002, Unilife has FDA-registered manufacturing facilities in the US State of Pennsylvania and a proprietary portfolio of clinical and prefilled safety syringes designed for use within healthcare and pharmaceutical markets.

Forward-Looking Statements

Certain statements in this transcription are about the future performance, events and developments of Unilife and are forward looking in nature. You should be aware that there are a number of risks, uncertainties, assumptions and other important factors, some of which are beyond the control of the company that could cause the actual performance, events and developments of Unilife to be materially different from those expressed or implied by such statements or that could cause future performance and results of Unilife to be materially different from its historical performance and results. You are cautioned about relying on these forward looking statements, and you should carefully read the filings we make from time to time with ASX and, in the future, with SEC before investing in our securities.